SEC Form 4 · accession 0001683168-18-000036
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon Surrey Barbari
Director
Period of report
Jan 2, 2018
Accepted (ET)
Jan 3, 2018 · 9:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per shareF1 | Jan 2, 2018 | A | 17,211 | — | A | 41,993 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The stock was granted by the Issuer as a bonus for services and vests immediately.